Clinical Trial Update: N-acetylcysteine in Bulimia Nervosa [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of N-acetylcysteine for bulimia nervosa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: NAC | Phase 2, Phase 3 | Status: TERMINATED